Novo Nordisk pays $26.7 million to settle claims
Danish drug company Novo Nordisk has agreed to pay $25 million to settle allegations that it promoted the misuse of blood clotting drug NovoSeven, the US Justice Department announced Friday.
Danish drug company Novo Nordisk has agreed to pay $25 million to settle allegations that it promoted the misuse of blood clotting drug NovoSeven, the US Justice Department announced Friday.
(PhysOrg.com) -- Changes in a person's eyes can show that they've seen something before, even when they're pretending they haven't, research by University of Sussex doctoral student Becky Heaver reveals.